78 related articles for article (PubMed ID: 23126204)
1. [Identification of two small molecule inhibitors of hypoxia-inducible factor 1 with different cell-based screening model].
Lang L; Tang K; Li Y; Liu X; Wang C; Chen X
Zhongguo Zhong Yao Za Zhi; 2012 Jul; 37(14):2151-5. PubMed ID: 23126204
[TBL] [Abstract][Full Text] [Related]
2. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
[TBL] [Abstract][Full Text] [Related]
4. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
[TBL] [Abstract][Full Text] [Related]
5. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
[TBL] [Abstract][Full Text] [Related]
6. [A novel HIF-1 inhibitor--manassantin A derivative LXY6099 inhibits tumor growth].
Lai FF; Liu XY; Niu F; Lang LW; Xie P; Chen XG
Yao Xue Xue Bao; 2014 May; 49(5):622-6. PubMed ID: 25151731
[TBL] [Abstract][Full Text] [Related]
7. Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide.
Zhou ZL; Luo ZG; Yu B; Jiang Y; Chen Y; Feng JM; Dai M; Tong LJ; Li Z; Li YC; Ding J; Miao ZH
Mol Cancer; 2010 Oct; 9():268. PubMed ID: 20932347
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of triptolide on proliferation of PC12 cells].
Huang HW; Qiu YH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):466-9. PubMed ID: 21180177
[TBL] [Abstract][Full Text] [Related]
9. [A study on the regulatory mechanisms of mitogen-activated protein kinase phosphatase-1 in hypoxia inducible factor-1 trans-activation].
Qiao TD; Liu CJ; Shi YQ; DU YL; Han S; Fan DM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):555-9. PubMed ID: 15949338
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of triptolide on lymph node metastasis in patients with non-Hodgkin lymphoma by regulating SDF-1/CXCR4 axis in vitro.
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Acta Pharmacol Sin; 2006 Nov; 27(11):1438-46. PubMed ID: 17049119
[TBL] [Abstract][Full Text] [Related]
11. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.
Kong D; Park EJ; Stephen AG; Calvani M; Cardellina JH; Monks A; Fisher RJ; Shoemaker RH; Melillo G
Cancer Res; 2005 Oct; 65(19):9047-55. PubMed ID: 16204079
[TBL] [Abstract][Full Text] [Related]
12. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
13. Saururus cernuus lignans--potent small molecule inhibitors of hypoxia-inducible factor-1.
Hossain CF; Kim YP; Baerson SR; Zhang L; Bruick RK; Mohammed KA; Agarwal AK; Nagle DG; Zhou YD
Biochem Biophys Res Commun; 2005 Aug; 333(3):1026-33. PubMed ID: 15967416
[TBL] [Abstract][Full Text] [Related]
14. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
[TBL] [Abstract][Full Text] [Related]
15. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
[TBL] [Abstract][Full Text] [Related]
16. Abietane diterpenes from Salvia miltiorrhiza inhibit the activation of hypoxia-inducible factor-1.
Dat NT; Jin X; Lee JH; Lee D; Hong YS; Lee K; Kim YH; Lee JJ
J Nat Prod; 2007 Jul; 70(7):1093-7. PubMed ID: 17583950
[TBL] [Abstract][Full Text] [Related]
17. Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway.
Mohammed KA; Jadulco RC; Bugni TS; Harper MK; Sturdy M; Ireland CM
J Med Chem; 2008 Mar; 51(5):1402-5. PubMed ID: 18278856
[TBL] [Abstract][Full Text] [Related]
18. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
19. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
20. MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status.
Li W; Liu Y; Li XX; Yu Y; Wu JJ; Wang Q; Huo H; Wang LM; Yang L
Planta Med; 2011 Jan; 77(1):27-31. PubMed ID: 20607649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
